Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Sundry Debtors

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Sundry Debtors History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Sundry Debtors ₹192 Cr₹205 Cr₹216 Cr₹100 Cr₹120 Cr

What is the latest Sundry Debtors ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Sundry Debtors ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹192 Cr based on Mar2023 Consolidated results.
Year Sundry Debtors
Mar2023₹192 Cr
Mar2022₹205 Cr
Mar2021₹216 Cr
Mar2020₹100 Cr
Mar2019₹120 Cr

How is Sundry Debtors of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Sundry Debtors % Change
Mar2023 ₹192 Cr
-6.27
Mar2022 ₹205 Cr
-4.81
Mar2021 ₹216 Cr
116.03
Mar2020 ₹100 Cr
-17.17
Mar2019 ₹120 Cr -

Compare Sundry Debtors of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹41,171.0 Cr 3.2% 16.9% 90.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹356,673.0 Cr -2.9% 0% 59.6% Stock Analytics
CIPLA ₹119,930.0 Cr 5.8% 6.2% 60.9% Stock Analytics
DIVIS LABORATORIES ₹109,446.0 Cr 5% 8% 25.9% Stock Analytics
ZYDUS LIFESCIENCES ₹108,261.0 Cr -2.6% 15.3% 114.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,830.6 Cr 0.9% -1.5% 32.2% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

3.2%

16.9%

90.5%

SENSEX

2%

2.3%

22.2%


You may also like the below Video Courses